Keyphrases
Anticoagulants
100%
Fibrillation
100%
International Normalized Ratio
100%
Vitamin K Antagonists
100%
Therapeutic Range
100%
Patient-level
40%
Vitamin K Antagonist Therapy
40%
Confidence Interval
20%
Pearson Correlation Coefficient
20%
Newly Diagnosed
20%
1-year Follow-up
20%
World Population
20%
Antiplatelet Therapy
20%
Range of Values
20%
Stroke Prevention in Atrial Fibrillation
20%
Total Variability
20%
Non-valvular Atrial Fibrillation
20%
Coefficient of Concordance
20%
Time in Therapeutic Range
20%
Nursing and Health Professions
Clinical Audit
100%
Anticoagulant Agent
100%
International Normalized Ratio
100%
Antivitamin K
100%
Atrial Fibrillation
40%
Confidence Interval
20%
Correlation Coefficient
20%
Medicine and Dentistry
Antithrombotic
100%
Fibrillation
100%
Vitamin K Antagonist
100%
Atrial Fibrillation
66%
Apoplexy
33%
Antiplatelet
33%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Antivitamin K
100%
Atrial Fibrillation
66%
Antiplatelet
33%
Biochemistry, Genetics and Molecular Biology
Vitamin K
100%
Atrial Fibrillation
66%
Agricultural and Biological Sciences
Vitamin K Antagonist
100%